2 results match your criteria: "The Old School Surgery[Affiliation]"

Objective: To compare the relative efficacy and safety of olmesartan medoxomil (OM) with atenolol, captopril and losartan in phase III trials on mild to severely hypertensive patients.

Design: Multi-centre, randomized, double-blind, parallel group, with dose-titration studies lasting 12 or 24 weeks.

Methods: Two studies respectively compared 10 mg OM once daily (o.

View Article and Find Full Text PDF